265 related articles for article (PubMed ID: 31713604)
1. Transactivation of SOX5 by Brachyury promotes breast cancer bone metastasis.
Chen M; Zou S; He C; Zhou J; Li S; Shen M; Cheng R; Wang D; Zou T; Yan X; Huang Y; Shen J
Carcinogenesis; 2020 Jul; 41(5):551-560. PubMed ID: 31713604
[TBL] [Abstract][Full Text] [Related]
2. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.
Pei XH; Lv XQ; Li HX
Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904
[TBL] [Abstract][Full Text] [Related]
3. FOX-A1 contributes to acquisition of chemoresistance in human lung adenocarcinoma via transactivation of SOX5.
Chen D; Wang R; Yu C; Cao F; Zhang X; Yan F; Chen L; Zhu H; Yu Z; Feng J
EBioMedicine; 2019 Jun; 44():150-161. PubMed ID: 31147293
[TBL] [Abstract][Full Text] [Related]
4. Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression.
Hu J; Tian J; Zhu S; Sun L; Yu J; Tian H; Dong Q; Luo Q; Jiang N; Niu Y; Shang Z
Br J Cancer; 2018 Jan; 118(1):88-97. PubMed ID: 29123266
[TBL] [Abstract][Full Text] [Related]
5. The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells.
Shimoda M; Sugiura T; Imajyo I; Ishii K; Chigita S; Seki K; Kobayashi Y; Shirasuna K
BMC Cancer; 2012 Aug; 12():377. PubMed ID: 22931165
[TBL] [Abstract][Full Text] [Related]
6. TWIST1-mediated transcriptional activation of PDGFRβ in breast cancer stem cells promotes tumorigenesis and metastasis.
Yeeravalli R; Kaushik K; Das A
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166141. PubMed ID: 33845139
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
Du R; Wu S; Lv X; Fang H; Wu S; Kang J
J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis.
Jin X; Zhu L; Cui Z; Tang J; Xie M; Ren G
Clin Transl Oncol; 2019 Sep; 21(9):1207-1219. PubMed ID: 30767161
[TBL] [Abstract][Full Text] [Related]
9. SALL4 promotes tumor progression in breast cancer by targeting EMT.
Chen T; Tsang JYS; Su XC; Li P; Sun WQ; Wong ILK; Choy KY; Yang Q; Tse GMK; Chan TH; Chow LMC
Mol Carcinog; 2020 Oct; 59(10):1209-1226. PubMed ID: 32835442
[TBL] [Abstract][Full Text] [Related]
10. Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment.
Tulotta C; Lefley DV; Freeman K; Gregory WM; Hanby AM; Heath PR; Nutter F; Wilkinson JM; Spicer-Hadlington AR; Liu X; Bradbury SMJ; Hambley L; Cookson V; Allocca G; Kruithof de Julio M; Coleman RE; Brown JE; Holen I; Ottewell PD
Clin Cancer Res; 2019 May; 25(9):2769-2782. PubMed ID: 30670488
[TBL] [Abstract][Full Text] [Related]
11. miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer.
Liu X; Bi L; Wang Q; Wen M; Li C; Ren Y; Jiao Q; Mao JH; Wang C; Wei G; Wang Y
Oncogene; 2018 Jun; 37(25):3426-3439. PubMed ID: 29555976
[TBL] [Abstract][Full Text] [Related]
12. Transfection of T-Box Transcription Factor
Akimoto N; Nakamura K; Hijioka H; Kume K; Matsumura Y; Sugiura T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453543
[TBL] [Abstract][Full Text] [Related]
13. The potential role of Brachyury in inducing epithelial-to-mesenchymal transition (EMT) and HIF-1α expression in breast cancer cells.
Shao C; Zhang J; Fu J; Ling F
Biochem Biophys Res Commun; 2015 Nov; 467(4):1083-9. PubMed ID: 26393908
[TBL] [Abstract][Full Text] [Related]
14. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
15. MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5.
Renjie W; Haiqian L
Cancer Lett; 2015 Jan; 356(2 Pt B):568-78. PubMed ID: 25305447
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.
Tan CC; Li GX; Tan LD; Du X; Li XQ; He R; Wang QS; Feng YM
Oncotarget; 2016 Nov; 7(48):79688-79705. PubMed ID: 27806311
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.
Palena C; Roselli M; Litzinger MT; Ferroni P; Costarelli L; Spila A; Cavaliere F; Huang B; Fernando RI; Hamilton DH; Jochems C; Tsang KY; Cheng Q; Lyerly HK; Schlom J; Guadagni F
J Natl Cancer Inst; 2014 May; 106(5):. PubMed ID: 24815864
[TBL] [Abstract][Full Text] [Related]
18. Understanding Molecular Pathways and Targets of Brachyury in Epithelial-mesenchymal Transition (EMT) in Human Cancers.
Song W; Gobe GC
Curr Cancer Drug Targets; 2016; 16(7):586-93. PubMed ID: 27018266
[TBL] [Abstract][Full Text] [Related]
19. WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling.
Ma J; Li J; Wang Y; Chen W; Zheng P; Chen Y; Sun Z; Liu J; Zhou Y; Wang J; Liu S; Han X
Biomed Pharmacother; 2020 Jan; 121():109617. PubMed ID: 31810139
[TBL] [Abstract][Full Text] [Related]
20. SMC1 promotes epithelial-mesenchymal transition in triple-negative breast cancer through upregulating Brachyury.
Li K; Ying M; Feng D; Chen Y; Wang J; Wang Y
Oncol Rep; 2016 Apr; 35(4):2405-12. PubMed ID: 26781859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
